We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Waters and Rosetta Biosoftware Collaborate to Advance the Analysis of Complex Biological Mixtures

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Waters and Rosetta Biosoftware Collaborate to Advance the Analysis of Complex Biological Mixtures"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Waters Corporation and Rosetta Biosoftware have announced a collaboration to develop interfaces that promote compatibility between their software platforms and Waters mass spectrometry-based systems.

Specifically, the companies will work together to ensure that Rosetta Biosoftware's solution for protein expression data management and analysis, the Rosetta Elucidator® system, will process and analyze mass spectrometry data generated from the Waters® Q-Tof Premier™ and Synapt™ High Definition Mass Spectrometry™ (HDMS) Systems.

The collaboration will focus on developing software interfaces between the Elucidator system and Waters instrument systems that will give scientists the capability to perform comprehensive qualitative and quantitative profiling of complex biological mixtures.

"We are pleased to enable compatibility between the Elucidator system, and our innovative UPLC/MSE data acquisition methods and instruments," said Tim Riley, Vice President and Managing Director – Pharmaceutical Business Operations, Waters Division.

"This collaboration will enable more of our customers to take advantage of our advanced mass spec technologies to comprehensively analyze the results of their most demanding experiments," Riley added.

"Collaboration with Waters will allow us to rapidly adapt to advances in Waters instrument technology, ensuring that our customers have continued access to a robust end-to-end solution," said Yelena Shevelenko, Vice President and General Manager of Rosetta Biosoftware. "The streamlined integration will improve research productivity and provide solutions for a broader scientific audience."

The Waters Corporation and Rosetta Biosoftware will be exhibiting their latest technologies at the 55th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, June 3 - 7, 2007 in Indianapolis, Indiana.